Effects of a lymphedema prevention program based on the theory of knowledge–attitude–practice on postoperative breast cancer patients: A randomized clinical trial
Cancer Medicine · 2023
DOI: 10.1002/cam4.6171 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Medicine, 2023. Verfasst von Bohui Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphedema, Breast Cancer Lymphedema. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Breast cancer‐related lymphedema (BCRL) is one of the common postoperative complications that severely affects the functions of the arm and quality of life. Since lymphedema is difficult to treat and prone to recurrence, early prevention of lymphedema is crucial.
Methods
Patient diagnosed with breast cancer ( N = 108) were randomized to the intervention ( n = 52) or control group ( n = 56). In the intervention group, patients were provided the lymphedema prevention program based on the theory of knowledge–attitude–practice during the perioperative period and the first three chemotherapy sessions (mainly includes health education, seminars, knowledge manuals, sports guidance, peer education, and WeChat group).The limb volume, handgrip strength, arm function, and quality of life were measured in all patients at the baseline, 9 weeks (T1), and 18 weeks (T2) after surgery.
Results
The incidence of lymphedema in the Intervention group was numerically lower than in the control group after implementing the lymphedema prevention program, but the difference was not statistically significant (T1: 1.9% vs. 3.8%, p = 1.000; T2: 3.6% vs. 7.1%, p = 0.744). However, compared with the control group, the intervention group showed there was less deterioration in handgrip strength (T1 [ t = −2.512, p < 0.05] and T2 [ t = −2.538, p < 0.05]), improved postoperative upper limb dysfunction (T1 [ t = 3.087, p < 0.05] and T2 [ t = 5.399, p < 0.05]) and less deterioration in quality of life (T1 [ p < 0.05] and T2 [ p < 0.05]).
Conclusion
Although the investigated lymphedema prevention program improved arm function and quality of life, it did not reduce the incidence of lymphedema in postoperative breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- School of Nursing, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- Department of Paediatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Infectious Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zitieren
APA
Shi, B., Lin, Z., Shi, X., Guo, P., Wang, W., Qi, X., Zhou, C., Zhang, H., Liu, X., & Iv, A. (2023). Effects of a lymphedema prevention program based on the theory of knowledge–attitude–practice on postoperative breast cancer patients: A randomized clinical trial. Cancer Medicine. https://doi.org/10.1002/cam4.6171
Vancouver
Shi B, Lin Z, Shi X, Guo P, Wang W, Qi X, et al. Effects of a lymphedema prevention program based on the theory of knowledge–attitude–practice on postoperative breast cancer patients: A randomized clinical trial. Cancer Medicine. 2023. doi:10.1002/cam4.6171
BibTeX
@article{Shi2023,
author = {Shi, Bohui and Lin, Zihan and Shi, Xiaowei and Guo, Pingli and Wang, Wen and Qi, Xin and Zhou, Can and Zhang, Huifang and Liu, Xiaona and Iv, Aili},
title = {Effects of a lymphedema prevention program based on the theory of knowledge–attitude–practice on postoperative breast cancer patients: A randomized clinical trial},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6171}
}
EUVIMED